$2.22
+0.17 (+8.29%)
Open$2.17
Previous Close$2.05
Day High$2.38
Day Low$2.08
52W High$67.00
52W Low$1.43
Volume—
Avg Volume179.6K
Market Cap168.78M
P/E Ratio—
EPS$-0.08
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 66.78M | 62.47M | 71.10M |
| Net Income | 5.53M | 4.95M | 5.20M |
| Profit Margin | 8.3% | 7.9% | 7.3% |
| EBITDA | 7.58M | 8.61M | 8.78M |
| Free Cash Flow | 4.38M | 4.03M | 6.15M |
| Rev Growth | +15.6% | -3.5% | +12.7% |
| Debt/Equity | 0.23 | 0.21 | 0.26 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $261.07 | +3.99% | 126.9 | 461.26B |
| AMGN | Amgen Inc | $374.15 | +3.55% | 25.9 | 201.93B |
| GILD | Gilead Sciences Inc | $131.27 | +4.21% | 17.7 | 162.98B |
| VRTX | Vertex Pharmaceuticals Inc | $528.04 | +6.03% | 30.4 | 131.79B |
| REGN | Regeneron Pharmaceuticals | $654.27 | +4.73% | 15.5 | 68.59B |
| ALNY | Alnylam Pharmaceuticals Inc | $312.78 | +3.68% | 72.4 | 41.76B |